ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,713.64
      1.70%
      US Tech 100
      19,296.40
      2.33%
      Dow Jones
      42,025.19
      1.26%
      Brent Oil
      74.32
      2.68%
      Bitcoin
      62,992.12
      2.14%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Nuvectis Pharma Inc (NVCT) Quote

      Nuvectis Pharma Inc

      Nuvectis Pharma Inc (NVCT)

      NASDAQ
      6.75
      0.05
      (0.75%)
      At close: September 19 4:00PM
      Delayed by 15 minutes
      6.75
      0.00
      ( 0.00% )
      After Hours: 5:02PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      6.75
      Bid
      6.70
      Ask
      7.00
      Volume
      69,076
      6.6123 Day's Range 6.99
      5.85 52 Week Range 14.9599
      Market Cap
      125.906M
      Previous Close
      6.70
      Open
      6.77
      Last Trade
      7
      @
      6.7
      Last Trade Time
      16:17:34
      Financial Volume
      $ 471,494
      VWAP
      6.8257
      Average Volume (3m)
      83,417
      Shares Outstanding
      18,652,688
      Dividend Yield
      -
      PE Ratio
      -5.63
      Earnings Per Share (EPS)
      -1.19
      Revenue
      -
      Net Profit
      -22.26M

      About Nuvectis Pharma Inc

      Nuvectis Pharma Inc is a biopharmaceutical company. Nuvectis Pharma Inc is a biopharmaceutical company.

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.nuvectis.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Nuvectis Pharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NVCT. The last closing price for Nuvectis Pharma was $6.70. Over the last year, Nuvectis Pharma shares have traded in a share price range of $ 5.85 to $ 14.9599.

      Nuvectis Pharma currently has 18,652,688 shares outstanding. The market capitalization of Nuvectis Pharma is $124.97 million. Nuvectis Pharma has a price to earnings ratio (PE ratio) of -5.63.

      Ask ADVFN Intelligence (AI)

      NVCT Latest News

      More News

      PESG Releases Report on Nuvectis Pharma: With Summit Therapeutics Threatening to Dethrone Merck's Keytruda, Nuvectis' NXP900 is One to Watch

      With its focus on targeting well-defined subgroups by inhibiting SRC/YES1 kinases in Non Small-Cell Lung Cancer patients resistant to EGFR and ALK targeted therapies, Nuvectis Pharma’s NXP900...

      September 16 2024
      Business Wire

      Form 8-K - Current report

      August 29 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 06 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 06 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 13 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      June 13 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 13 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      May 13 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      May 07 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      May 07 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.324.97667185076.437.046.00011144146.53737038CS
      4-0.44-6.119610570247.197.55.911079196.67668972CS
      120.253.846153846156.57.65.85834176.66009918CS
      26-4.08-37.673130193910.8311.415.85837406.82492281CS
      52-7.83-53.703703703714.5814.95995.85795987.85583013CS
      1562.870.88607594943.9520.923.081910587.94177113CS
      2602.870.88607594943.9520.923.081910587.94177113CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      LFLYLeafly Holdings Inc
      $ 3.75
      (109.50%)
      		4.72M
      AENTAlliance Entertainment Holding Corporation
      $ 2.87
      (40.69%)
      		122.64k
      TNONTenon Medical Inc
      $ 6.5095
      (29.41%)
      		2.74M
      AEMDAethlon Medical Inc
      $ 0.4896
      (25.54%)
      		8.49M
      LDTCLeddarTech Holdings Inc
      $ 0.3631
      (21.85%)
      		193.08k
      EJHE Home Household Service Holdings Ltd
      $ 0.0788
      (-19.26%)
      		8.84M
      KOPNKopin Corporation
      $ 0.80
      (-17.02%)
      		193.73k
      JFBRJeffs Brands Ltd
      $ 0.262
      (-14.38%)
      		14.48k
      NCINeo Concept International Group Holdings Ltd
      $ 0.731
      (-12.98%)
      		1.57M
      RZLVRezolve AI Ltd
      $ 6.329
      (-9.59%)
      		40.81k
      EJHE Home Household Service Holdings Ltd
      $ 0.0788
      (-19.26%)
      		8.84M
      AEMDAethlon Medical Inc
      $ 0.4896
      (25.54%)
      		8.49M
      HSTHost Hotels and Resorts Inc
      $ 18.53
      (0.00%)
      		6.45M
      LFLYLeafly Holdings Inc
      $ 3.75
      (109.50%)
      		4.72M
      SQQQProShares UltraPro Short QQQ
      $ 7.785
      (0.32%)
      		4.69M

      NVCT Discussion

      View Posts
      Monksdream Monksdream 2 weeks ago
      NVCT under $10
      👍️0
      Monksdream Monksdream 3 months ago
      NVCT under $10
      👍️0
      Monksdream Monksdream 5 months ago
      NVCT under $10
      👍️0
      Monksdream Monksdream 7 months ago
      NVCT 10Q due March 6
      👍️0
      Monksdream Monksdream 8 months ago
      NVCT a bounce
      👍️0
      conix conix 2 years ago
      NVCT HIGHLIGHTS:

      *Recently completed Initial Public Offering - $5.00 Per share
      *2 Precision Cancer medicines in development - ovarian and triple negative breast
      *Data flow throughout 2022
      *CEO with multiple success stories in life science sector to $billion dollar market caps
      *Analysts project a $66 billion precision medicines market for 2021; In 6 years, this number is expected to top $140 billion

      Nuvectis Pharma Inc - Company Background:

      Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for serious conditions of unmet medical need in oncology. The Company is currently developing two drug candidates: NXP800, a clinical-stage HSF1 pathway inhibitor currently in a Phase 1 study in patients with advanced solid tumors, and NXP900, a novel SRC/YES1 kinase inhibitor currently in preclinical development with IND-enabling studies ongoing.

      Market Capitalization: $225 million
      Range - 52 week: $3.08 - $20.75
      Current Price: $20.44
      Trades on: Nasdaq Capital Market
      Ticker Symbol: NVCT

      website: nuvectis.com
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      wow from $3 to almost $21
      👍️0
      ipo_dude ipo_dude 2 years ago
      $27 we come
      👍️0
      TheFinalCD TheFinalCD 3 years ago
      WOW $7 MOVE 3-10


      CONGRAT$ NVCT
      👍️0
      spindog spindog 3 years ago
      I feel the same
      👍️0
      kkballa kkballa 3 years ago
      hmmm.
      👍️0

      Your Recent History

      NASDAQ
      NVCT
      Nuvectis Pharma
      Delayed Upgrade Clock